Scrutinizing Novel Targets Including Trop-2, DLL3 & CEACAM5 as Potential New Targets with Optimal Expression to Enhance Target Validation & Translational Relevance & Move Beyond “Me-Too” Drugs

10:59 am - Wednesday 25th February 2026